SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the focal point, with traders watching guidance, subscriber engagement, advertising growth, and content strategy amid leadership changes and layoffs. Bearish concerns about competition, content quality, and slowing growth contrast with bullish hopes that low expectations and ad expansion could support a positive reaction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally and renewed attention center on traders positioning ahead of the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously positive topline results. Bulls see the readout as validation of a broader oncology platform, while skeptics argue the rally has outpaced the evidence and could unwind in a sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp move is drawing attention as shares push above recent technical resistance, while traders point to anticipated DM1 and FSHD siRNA data as potential catalysts. Some see strength or possible short covering, while others caution that past rallies have faded and no new catalyst is confirmed in the discussion.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are falling amid concern over plans to list its Monee financial-services arm and launch Sea Cloud, which traders worry could add spending and strategic uncertainty. The community is split between viewing a Monee separation as a potential value unlock and fearing it could weaken the remaining business, while some see the selloff as an overreaction.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs earnings beat and raised outlook have been met with a sharp selloff, prompting frustration and debate over why strong demand and guidance have not supported the shares. Traders point to profit-taking and elevated expectations, while cost pressures, weaker cash conversion and an insurance-unit loss have raised questions about margins and the quality of the results.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, driving attention to the drugs potential and analyst optimism. Traders are debating whether the placebo-adjusted benefit is modest and whether agitation concerns and higher discontinuations could limit the upside, with some viewing the move as vulnerable to a fade.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving attention and a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic reset. Others argue the divestiture removes a meaningful revenue stream and leaves concerns about debt and the remaining businesss growth unresolved.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers push to a fresh 52-week high is drawing attention, with traders celebrating a long-awaited recovery and debating whether the breakout can hold or will meet resistance. Some point to defensive-sector demand and pipeline progress, while others say the move needs a clearer company-specific catalyst.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention is centered on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel results in progressive MS, alongside new BRIUMVI data. Traders are hopeful azer-cel could add a growth opportunity beyond BRIUMVI, while recognizing the early readouts efficacy is uncertain; continued BRIUMVI sales growth is the more established part of the story.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's Why You Should Consider Investing in Nordson Stock Now

NDSN's strong end-market demand, strategic acquisitions and raised fiscal 2026 guidance boost its growth prospects. Is the stock worth buying now?

MWA or NDSN: Which Is the Better Value Stock Right Now?

MWA vs. NDSN: Which Stock Is the Better Value Option?

Reasons Why Investors Should Consider Investing in Helios Stock

HLIO is benefiting from improving demand, margin expansion and shareholder returns, with 2026 earnings expected to rise 24.6%.

Reasons Why Investors Should Consider Investing in Nordson Stock

NDSN is benefiting from broad-based business strength, acquisition gains and shareholder returns as it invests in long-term growth.

Nordson (NDSN) Down 6.9% Since Last Earnings Report: Can It Rebound?

Nordson (NDSN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Are Industrial Products Stocks Lagging  Helios Technologies (HLIO) This Year?

Here is how Helios Technologies (HLIO) and Nordson (NDSN) have performed compared to their sector so far this year.

Nordson's 2026 Outlook: Recurring Revenue Base Drives Sustained Long-Term Profitability

Key PointsNordson maintains a critical role in semiconductor packaging and medical device manufacturing hardware...

Top Research Reports for S&P Global, Cloudflare & Canadian Natural

Cloudflare's enterprise demand, AI-driven adoption and raised 2026 outlook support growth, but margin pressure and competition keep risk balanced.

Buy 3 Manufacturing Robotics Bigwigs Amid Solid Price Upside Potential

EMR, NDSN and ZBRA offer double-digit short-term upside, backed by automation demand and solid growth prospects.


Nordson Corp. engages in the engineering, manufacture and market of products and systems used for adhesives, coatings, sealants, biomaterials and other materials. It operates through the following segments: Industrial Precision Solutions, Medical and Fluid Solutions and Advanced Technology Solution. The Industrial Precision Solutions segment enhances the technology synergies between adhesive dispensing systems and industrial coating systems to deliver proprietary dispensing and processing technology to diverse end markets. The Medical and Fluid Solutions segment includes components and device solutions for medical, life science, high-tech industrial and other diverse end markets. The Advanced Technology Solution segment integrates proprietary product technologies found in progressive stages of a customer's production processes, such as surface treatment, precisely controlled dispensing of material and post-dispense test and inspection to ensure quality. The company was founded by Eric T. Nord, Evan W. Nord and Walter G. Nord in 1954 and is headquartered in Westlake, OH.

Nordson Corp.

Why Is Nordson Stock Rising In Premarket Trading? 

Equity

Neutral Sentiment

Nordson stock (NDSN) rose 5.5% in premarket trading on Thursday after the company’s third-quarter earnings topped Wall Street’s estimates.The company reported adjusted earnings of $2.73 per share for the quarter ended July 31, while analysts expected it to post $2.64 per share, according to Fiscal.ai data. The adhesive dispenser maker’s quarterly revenue of $741.5 million also topped estimates of $723.6 million.The Westlake, Ohio-based company reported earnings of $126 million, or $2.22 per share, compared with $117 million, or $2.04 per share, a year earlier.The medical and fluid solutions segment sales jumped 32% to $219 million compared to the same period last year. Last year, the company completed the $815 million acquisition of Atrion Corporation, a medical technology company specializing in infusion and cardiovascular solutions.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/NDSN">Nordson</a> was in the ‘extremely bullish’ territory, while the retail chatter was ‘high.’Advanced technology solutions sales of $171 million increased 17%, driven by a rise in organic sales.However, industrial precision solutions sales of $351 million increased a more modest 1% as a three percentage point favorable currency impact helped mitigate a 2% drop in organic sales.The organic sales decrease was driven by weaker systems demand in polymer processing, offsetting growth in most other product lines.“Fiscal full-year sales are now tracking slightly below the mid-point, and full-year adjusted earnings per share are now tracking slightly above the mid-point of our original guidance,” the company said. Nordson also noted that backlog fell 5% sequentially.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/eurozone-s-factory-activity-surges-to-over-3-year-high-despite-trump-tariffs/chsSA0oRdLU">Eurozone’s Factory Activity Surges To Over 3-Year High Despite Trump Tariffs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Nordson Corporation logo appears on a smartphone screen in this illustration photo in Reno, United States, on December 30, 2024. (Photo by Jaque Silva/NurPhoto via Getty Images)

The company reported adjusted earnings of $2.73 per share for the quarter ended July 31, while analysts expected it to post $2.64 per share, according to Fiscal.ai data.

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Stocktwits Polls

We've got another potential Long setup on  $NDSN  
 in the middle of an ascending triangle formation. Any move above $338 and the stock will be in all-time high territory with no overhead resistance.

Vince Vora

$NDSN Nordson demonstrates a compelling setup driven by a recent 35 percent surge in order backlogs and robust institutional net buying, underpinning our bullish stance as of 10 Oct 2026. While the valuation is undeniably expensive in the near term, structural financial strength shines through 55 percent gross margins and high free cash flow generation. Technically, the multi-year price uptrend remains firmly intact above the 200-day moving average, supported by low short interest and constructive sell-side consensus. As detailed in the chart attached, our conviction averages 3.62 out of 5 across horizons. We would turn bearish if order cancellations reverse the backlog gains and the primary moving averages fail to hold support.  
 
(Disclosure: we're @astuteoptics1 and this is our own research.)

Astute Optics

Top 3 #momentum #stocks In The GorillaTrades #portfolio This Week: Nordson $NDSN +4.5%, Vertex Pharmaceuticals $VRTX +3.4%, and Descartes Systems $DSGX +2.5%

Feed

News

Sentiment

Earnings

Fundamentals

Info

NDSN Nordson Corp.

Fundamentals

Latest NDSN News